Revenue: As of FY2025 Q3, the actual value is USD 31.07 M.

EPS: As of FY2025 Q3, the actual value is USD 0.04.

EBIT: As of FY2025 Q3, the actual value is USD 3.262 M.

Healthcare IT Segment

Net Revenue

• $75.6 million for the nine months ended September 30, 2025
• $26.8 million for the three months ended September 30, 2025

Operating Expenses

• Direct Operating Costs: $37.9 million for the nine months ended September 30, 2025
• Selling and Marketing: $3.4 million for the nine months ended September 30, 2025
• General and Administrative: $7.4 million for the nine months ended September 30, 2025
• Research and Development: $3.8 million for the nine months ended September 30, 2025
• Depreciation and Amortization: $10.5 million for the nine months ended September 30, 2025
• Restructuring Costs: $154,000 for the nine months ended September 30, 2025

Operating Income

• $12.4 million for the nine months ended September 30, 2025
• $4.2 million for the three months ended September 30, 2025

Medical Practice Management Segment

Net Revenue

• $10.5 million for the nine months ended September 30, 2025
• $4.2 million for the three months ended September 30, 2025

Operating Expenses

• Direct Operating Costs: $8.3 million for the nine months ended September 30, 2025
• Selling and Marketing: $22,000 for the nine months ended September 30, 2025
• General and Administrative: $1.9 million for the nine months ended September 30, 2025
• Depreciation and Amortization: $246,000 for the nine months ended September 30, 2025

Operating Income

• $123,000 for the nine months ended September 30, 2025
• $502,000 for the three months ended September 30, 2025

Consolidated Metrics

Total Net Revenue

• $86.1 million for the nine months ended September 30, 2025
• $31.1 million for the three months ended September 30, 2025

Total Operating Expenses

• $77.9 million for the nine months ended September 30, 2025
• $27.9 million for the three months ended September 30, 2025

Operating Income

• $8.2 million for the nine months ended September 30, 2025
• $3.2 million for the three months ended September 30, 2025

Net Income

• $7.9 million for the nine months ended September 30, 2025
• $3.1 million for the three months ended September 30, 2025

Cash Flow

Operating Cash Flow

• $19.9 million for the nine months ended September 30, 2025

Free Cash Flow

• Net cash used in investing activities: - $21.2 million for the nine months ended September 30, 2025

Future Outlook and Strategy

Core Business Focus

• The company plans to continue enhancing its liquidity and financial position by managing expenses and growing revenue. Management expects these efforts to improve profitability and overall financial health.

Non-Core Business

• The company acquired MAP App, a hospital benchmarking tool, and created a new subsidiary, N884AM Holdings, Inc., for purchasing an aircraft to visit current and prospective clients.